The Rise of Advanced Technologies in the Pharmaceutical Industry
Deep Pharma Intelligence is inviting you to participate in a 3-day virtual event (November 15-17), which is a unique opportunity to learn insights and case studies from two major proprietary analytical reports by the company: “Landscape of Advanced Technology Companies in the Pharmaceutical Industry”, and “AI for Drug Discovery, Biomarker Development, and Advanced R&D Landscape”.
Invited guest speakers from high profile organizations will also share case studies for AI and advanced tech applications in the pharmaceutical industry, and their vision on the tech-enabled transformation of the biopharmaceutical industry. Several major technological topics will include:
Artificial Intelligence in Drug Discovery and Clinical Research
“Big Tech” corporations entering Pharma space
Other Supporting Technologies
The day 3 of the conference will be focused on the investment landscape and financial trends in the biopharma, healthcare, and longevity industries.
Day 1 (November 15, 5—8PM GMT)
How Advanced Technologies Are Shaping Pharmaceutical Industry
Disruptive technologies and emerging trends such as robotics, artificial intelligence, precision medicine, and patient design will have an impact on pharmaceutical manufacturing and distribution.
Invited specialists and DKG professionals will give speeches regarding these arising tendencies and technologies in use.
Day 2 (November 16, 5—8PM GMT)
Artificial Intelligence in Drug Discovery: Current State and Looking Forward
Astounding advances in computational power, combined with advancements in AI technology, are revolutionizing the drug development process.
At this event, on the one hand, we will discuss how AI improves the efficiency of drug development, as well as how pharmaceutical industry titans can collaborate with AI-powered drug discovery firms to sustain their drug development programs. On the other hand, the event will highlight big-tech companies' partnerships with drug discovery businesses.
Day 3 (November 17, two sessions: 10 AM-1 PM GMT and 5 — 8PM GMT)
Technology Investment Landscape: Pharma, Biotech, Longevity Industry
Longevity and biotech industries are poised for a massive leap in the near future, owing to the impact of AI on biomedicine R&D and the impending paradigm shift from treatment to preventative measures.
The final conference event will shed light on key observations in the rapidly evolving and exponentially growing Longevity Industry's private equity, venture capital ecosystem and SPACs.